Revolutionary Insights & Engineering Excellence
in Cardiac Healthcare
Cutting-Edge Technologies for Precise Diagnosis, Monitoring & Intervention Planning
Cardiac device development services
Providing engineering and efficacy and efficiency assessment service to cardiovascular device manufacturers and pharmaceutical companies and clinical teams
Diganics specializes in developing innovative cardiovascular devices and diagnostic tools. A key focus of its activities is providing technical support to medical device companies and physicians in engineering, development, and validation of cardiovascular devices and speed up the commercialization process particularly transcatheter, surgical and mechanical heart valves.
Pioneering extensive analysis of heart valve replacement outcome
Unique arsenal for device development with unprecedentedly accurate prediction of
transcatheter and surgical heart valve outcomes
Design optimization
Advanced patient-specific computational tools to optimize the design based on real-life conditions.
Computational device efficacy assessment
Advanced patient-specific computational tools to simulate the efficacy of device.
Advanced prototyping
Advanced methods, tools and frameworks to make the patient-specific 3-D prints.
In vitro device efficacy assessment
State-of-the-art patient-specific in vitro simulator to test the efficacy of the devices.
Detailed flow characterization
Advanced high-speed high-resolution 4-camera particle image velocimetry measurement.
Verification with clinical imaging
Advanced imaging systems and advanced clinical ultrasound machines for verification.
Ex vivo device efficacy assessment
Advanced methods, tools and frameworks to make the patient-specific 3-D prints.
In vitro disease assessment
State-of-the-art patient-specific in vitro simulator to test assess and classify the disease.
The FDA has recognized that patient-specific computational modeling applications are continually expanding and becoming a critical component of medical device development. These applications play an increasingly significant role in providing evidence of safety and performance in regulatory submissions. Diagnics’ computational algorithms and experimental setups support all requirements outlined by the FDA in its guidance document.
(Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions November 17, 2023.)
Our unique cutting-edge technology embedded in DiagnoCardio enables highly accurate noninvasive diagnosis and personalized treatment planning.
DiagnoCardio
The only non-invasive ventricle Pressure – Volume Loop medical device
An advanced patented noninvasive clinical device for cardiac diagnosis and monitoring
Continuous monitoring with diagnosis accuracy
Diagnics benefits from multiple patents and is advancing the commercialization of DiagnoCardio for accurate cardiac monitoring in addition to diagnosis.
Clinical decision making
DiagnoCardio was developed to enhance and streamline decision making process for clinical teams.
Do you have an innovative cardiovascular device idea?
Our engineering team—specialized in the design, research, and development of cardiovascular devices—offers comprehensive, end-to-end support to companies, clinical teams, and individual innovators. From conceptualization to bedside application, we guide you through every stage of development and commercialization, transforming your vision into a tangible, life-saving solution.